Frequently Asked Questions
The Oxygen Therapy Market involves devices and systems for delivering supplemental oxygen to patients with low blood oxygen levels, including source equipment and delivery tools for managing respiratory conditions.
Key factors include rising chronic respiratory diseases, technological advancements in portable devices, aging populations, increasing home healthcare demand, and supportive government initiatives.
The market is projected to grow from approximately USD 38.9 billion in 2026 to USD 75.3 billion by 2035.
The CAGR is expected to be 6.8% from 2026 to 2035.
North America will contribute notably, holding around 35% of the market value due to advanced infrastructure and high disease prevalence.
Major players include Inogen, Inc., ResMed Inc., Philips Respironics, Invacare Corporation, Fisher & Paykel Healthcare Limited, Chart Industries, Inc., Linde plc, Drägerwerk AG & Co. KGaA, Teleflex Incorporated, and DeVilbiss Healthcare.
The report provides comprehensive analysis including market size, trends, segmentation, key players, regional insights, and forecasts from 2026 to 2035.
Stages include raw material sourcing, device manufacturing and assembly, quality testing and certification, distribution and sales, end-user training, and after-sales service with maintenance.
Trends are shifting towards portable, smart devices with IoT integration, while consumers prefer user-friendly, comfortable solutions for home use that enhance mobility and adherence.
Factors include FDA approvals for safety, reimbursement policies expanding access, and environmental pushes for energy-efficient devices to reduce carbon emissions from manufacturing.